HCW Biologics Inc is a preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation and age-related diseases. It is developing HCW9218 as an injectable immunotherapeutic for patients with solid tumors.

Earnings

Q4 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2022-02-15
REV		(EXPECTED)2022-02-15

Q3 2021		Est.		Actual		Surprise
EPS				-0.140
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

HCW Biologics Questions & Anwsers

How do I buy HCW Biologics (HCWB) stock?

You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.

View our list of the best stock brokerages.

Who are HCW Biologics's (HCWB) competitors?

There are no as such competitors for HCW Biologics.

What is the target price for HCW Biologics (HCWB) stock?

The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on November 19, 2021. The analyst firm set a price target for 10.00 expecting HCWB to rise to within 12 months (a possible 280.23% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for HCW Biologics (HCWB)?

The stock price for HCW Biologics (NASDAQ: HCWB) is $2.63 last updated Fri Dec 03 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Does HCW Biologics (HCWB) pay a dividend?

There are no upcoming dividends for HCW Biologics.

When is HCW Biologics (NASDAQ:HCWB) reporting earnings?

HCW Biologics’s $Q4 earnings are confirmed for after-market on February 15, 2022.

Is HCW Biologics (HCWB) going to split?

There is no upcoming split for HCW Biologics.

What sector and industry does HCW Biologics (HCWB) operate in?

HCW Biologics is in the sector and industry. They are listed on the NASDAQ.

QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD